Syros Pharmaceuticals Inc’s recently made public that its Director AKKARAJU SRINIVAS acquired Company’s shares for reported $2306.0 on Dec 30 ’24. In the deal valued at $0.25 per share,9,333 shares were bought.
Then, Flagship Pioneering Fund VII, bought 1,331,624 shares, generating $279,641 in total proceeds.
Before that, Flagship VentureLabs IV LLC bought 21,333 shares. Syros Pharmaceuticals Inc shares valued at $4,907 were divested by the Affiliate at a price of $0.23 per share.
H.C. Wainwright upgraded its Syros Pharmaceuticals Inc [SYRS] rating to a Buy from a a Neutral in a research note published on November 04, 2020; the price target was increased to $15 from $11. A number of analysts have revised their coverage, including Alliance Global Partners’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Wedbush also remained covering SYRS and has decreased its forecast on January 17, 2020 with a “Neutral” recommendation from previously “an Outperform” rating.
Price Performance Review of SYRS
On Friday, Syros Pharmaceuticals Inc [NASDAQ:SYRS] saw its stock jump 5.61% to $0.24. Over the last five days, the stock has gained 12.55%. Syros Pharmaceuticals Inc shares have risen nearly 5.74% since the year began. Nevertheless, the stocks have fallen -96.56% over the past one year. While a 52-week high of $7.98 was reached on 01/03/25, a 52-week low of $0.18 was recorded on 01/02/25. SMA at 50 days reached $0.9057, while 200 days put it at $3.4048.
Levels Of Support And Resistance For SYRS Stock
The 24-hour chart illustrates a support level at 0.2274, which if violated will result in even more drops to 0.2117. On the upside, there is a resistance level at 0.2624. A further resistance level may holdings at 0.2817. The Relative Strength Index (RSI) on the 14-day chart is 35.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0177, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.02%. Stochastics %K at 36.71% indicates the stock is a holding.
How much short interest is there in Syros Pharmaceuticals Inc?
A steep rise in short interest was recorded in Syros Pharmaceuticals Inc stocks on 2024-12-13, dropping by -3.21 million shares to a total of 1.57 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 4.77 million shares. There was a decline of -204.94%, which implies that there is a negative sentiment for the stock.
